Profile picture

Doctor Sofia Andraz

Algarve University Hospital Center, Faro (Portugal)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

A heart under crossfire: the diagnostic challenge of left ventricular dysfunction
Presentation
A heart under crossfire: the diagnostic challenge of left ventricular dysfunction
A vacation turned emergency: decoding a life-threatening arrhythmia
Presentation
A vacation turned emergency: decoding a life-threatening arrhythmia
Diagnostic challenge of myocarditis: what lies behind parvovirus B19?
Presentation
Diagnostic challenge of myocarditis: what lies behind parvovirus B19?
Evaluating superresponse in CRT: a clinical edge or just a remodeling effect?
Presentation
Evaluating superresponse in CRT: a clinical edge or just a remodeling effect?
Predictors for adverse outcomes in ICD/CRT-D patients: insights from a single-center study
Presentation
Predictors for adverse outcomes in ICD/CRT-D patients: insights from a single-center study
The current impact of atrial fibrillation on prognosis in patients with acute coronary syndrome
Presentation
The current impact of atrial fibrillation on prognosis in patients with acute coronary syndrome
Outcome predictors in acute coronary syndrome in patients submitted to percutaneous coronary intervention
Presentation
Outcome predictors in acute coronary syndrome in patients submitted to percutaneous coronary intervention
A global perspective on lipid control after acute coronary syndrome: are we doing enough?
Presentation
A global perspective on lipid control after acute coronary syndrome: are we doing enough?
Electrical cardioversion of long-standing persistent atrial fibrillation: the importance of antiarrhythmic pretreatment
Presentation
Electrical cardioversion of long-standing persistent atrial fibrillation: the importance of antiarrhythmic pretreatment
Enhancing primary prevention: the incremental predictive value of high-sensitivity cardiac troponin T beyond ASCVD risk assessment
Presentation
Enhancing primary prevention: the incremental predictive value of high-sensitivity cardiac troponin T beyond ASCVD risk assessment

ESC 365 is supported by